An update on DOT1LWT/MUT modulators as a promising anticancer strategy
{{output}}
Disruptor of telomeric silencing 1-like (DOT1L) is the only identified H3K79 methyltransferase and its dysregulation, mutations, or aberrant activity are closely implicated in the pathogenesis and progression of various diseases. Due to their key roles in leuk... ...